Catalyst Event
Tempus AI Inc (TEM) · Other
From KEDI U.S. Medical AI Index (KUSMAI)
3/17/2026, 12:00:00 AM
Announced a strategic collaboration with Blood Cancer United® on March 17, 2026. Low importance estimated as such partnerships typically have limited immediate market impact.
Korean Translation
2026년 3월 17일, Blood Cancer United®와의 전략적 협력 발표함. 이러한 협력은 통상적으로 즉각적인 주가 영향이 제한적이므로 낮은 중요도로 예상함.
Related Recent Events
Alphabet Inc (GOOGL) · Other
Google I/O 2026 developer conference is scheduled for 2026-05-19. Developer conferences usually have a 1-5% price impact. Updates on AI, Gemini, and Android are expected.
5/19/2026, 12:00:00 AM
Hims & Hers Health Inc (HIMS) · Earnings Release
Q1 2026 earnings release is scheduled for 2026-05-11. Analysts forecast revenue between $600M-$625M and adjusted EBITDA of $35M-$55M. Low importance is estimated as the market typically anticipates scheduled earnings results, which is forecasted.
5/11/2026, 12:00:00 AM
BioNTech SE (BNTX) · Earnings Release
First quarter 2026 earnings results and conference call scheduled.
5/5/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Earnings Release
Q1 2026 earnings release on May 5, 2026, with low importance estimated as the date is unconfirmed, expected.
5/5/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Q1 2026 earnings release scheduled. Analysts forecast EPS around $7.25-$7.50 estimated. High importance estimated due to the significant weight of earnings reports on stock volatility.
4/30/2026, 12:00:00 AM
AbbVie Inc (ABBV) · Earnings Release
First quarter 2026 earnings release; importance is estimated as Medium because quarterly earnings reports often result in price movements exceeding 5%, scheduled.
4/24/2026, 12:00:00 AM